Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010

YH Chen, PL Lu, CH Huang, CH Liao… - Antimicrobial agents …, 2012 - Am Soc Microbiol
… a nationwide, prospective surveillance during 2006 to 2010, collected a total of 7,793 clinical
isolates… Among ESBL-producing Enterobacteriaceae, tigecycline still showed potent in vitro

[PDF][PDF] … activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter …

YH Ku, YC Chuang, WL Yu - J Microbiol Immunol Infect, 2008 - researchgate.net
… In global surveillance studies of the in vitro activity of tigecyclineNationwide study of
Escherichia coli and Klebsiella … cloacae isolates from a district teaching hospital in Taiwan. Clin …

[PDF][PDF] In vitro activities of nine current antibiotics against culprit bacteria in nosocomial infections in an institution in Northern Taiwan

SC Lee, SS Huang, LC See, MH Tsai… - Chang Gung Med …, 2011 - cgmj.cgu.edu.tw
… coli with extended-spectrum beta-lactamase (ESBL), the most … for tigecycline susceptibility
testing against clinical isolates of … against AmpC beta-lactamase-producing Escherichia coli. J …

In vitro and in vivo evaluations of β-lactam/β-lactamase Mono-and combined therapies against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan

TY Yang, YJ Hsieh, LT Kao, GH Liu, SH Lian, LC Wang… - Microorganisms, 2020 - mdpi.com
… of a nationwide surveillance project in Taiwan. Bioinformatic … resistant to colistin, amikacin,
or tigecycline [9]. In the present … -nonsusceptible Enterobacteriaceae clinical isolates collected …

… gram-negative bacteria with emphasis on community-acquired resistant isolates: report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan  …

PY Liu, YL Lee, MC Lu, PL Shao, PL Lu… - Antimicrobial agents …, 2020 - Am Soc Microbiol
monitoring the in vitro resistance of clinically important bacteria obtained from hospitals
throughout Taiwan … Continued surveillance of carbapenem-resistant Enterobacteriaceae in the …

… and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020

CH Chen, PH Wu, MC Lu, MW Ho, PR Hsueh - International Journal of …, 2023 - Elsevier
… This study evaluated the in-vitro activity of multiple classes of … , ceftolozone/tazobactam
against extended-spectrum β-… , India and Taiwan were the only countries that showed tigecycline-…

[HTML][HTML] Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and …

HJ Tang, CC Lai, CC Chen, CC Zhang… - Journal of Microbiology …, 2019 - Elsevier
… A national surveillance of CRE in Taiwan in 2011 … For in vitro combination experiments, one
to three isolates were randomly selected from the five types, with a total of 13 clinical isolates

Klebsiella pneumoniae harboring carbapenemase genes in Taiwan: its evolution over 20 years, 1998–2019

CC Lai, WL Yu - International Journal of Antimicrobial Agents, 2021 - Elsevier
… lactamase production such as extended-spectrum β-lactamase … resistance developed in a
clinical isolate of ESBL-producing … may exhibit in vitro activity against CnSKP, clinicians should …

[PDF][PDF] … and characterization of carbapenem-resistant Klebsiella pneumoniae isolated from urine at a teaching hospital in Taiwan. Microorganisms 2021; 9: 271

YJ Lee, CH Huang, NA Ilsan, IH Lee, TW Huang - 2021 - academia.edu
… All isolates carried at least one other extended-spectrum β-… Nationwide surveillance of
the prevalence of carbapenem-… in our clinical isolates (shown in Figure 2). Four ST11-KL64 …

Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae

PL Chen, JJ Yan, CJ Wu, HC Lee, CM Chang… - … and infectious disease, 2010 - Elsevier
… He was finally treated successfully using tigecycline. Ertapenem resistance was … tigecycline
may be an alternative for invasive infections caused by ESBL-producing Enterobacteriaceae